Apollo Biowellness Inc (KOAN) Stock Price & News

All values in USD	2024-ж. сен.	2024-ж. дек.	2025-ж. мар.
Revenue	598,63 миң	546,31 миң	430,77 миң
Cost of goods sold	179,16 миң	182,94 миң	140,72 миң
Cost of revenue	179,16 миң	182,94 миң	140,72 миң
Research and development expenses	3,51 миң	-	-
Total research and development expenses	-	-	-
Selling, general, and admin expenses	685,72 миң	714,03 миң	620,28 миң
Operating expense	689,23 миң	714,03 миң	620,28 миң
Total operating expenses	868,38 миң	896,97 миң	761,01 миң
Operating income	-269,76 миң	-350,66 миң	-330,24 миң
Other non operating income	-	3,37 миң	215,00
EBT including unusual items	-305,50 миң	-577,44 миң	-411,82 миң
EBT excluding unusual items	-273,04 миң	-577,44 миң	-411,82 миң
Income tax expense	-	-	-
Effective tax rate	-	-	-
Other operating expenses	-	-	-
Net income	-305,50 миң	-577,44 миң	-411,82 миң
Net profit margin	-51,03%	-105,70%	-95,60%
Earnings per share	-	-	-
Interest and investment income	-	-	-
Interest expense	-3,28 миң	-230,15 миң	-81,79 миң
Net interest expenses	-3,28 миң	-230,15 миң	-81,79 миң
Depreciation and amortization charges	-	-	-
EBITDA	-269,76 миң	-350,66 миң	-325,96 миң
Gain or loss from assets sale	69,24 миң	-	-

Ask anything